A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis
- Jiménez-Morales, A.
- Cáliz, R.
- Aceituno, S.
- Prades, M.
- Blanch, C.
ISSN: 1885-1398, 1699-258X
Argitalpen urtea: 2021
Alea: 17
Zenbakia: 9
Orrialdeak: 536-542
Mota: Artikulua